Reveals blocking cytokine signaling restrains metastasis in triple-negative breast cancer, suggesting a new treatment approach.
. Our findings reveal that blocking cytokine receptor signaling disrupts the pro-metastatic crosstalk between macrophages and TNBC cells, offering a clinically actionable strategy to restrain metastasis and overcome therapy resistance in TNBC.
No takes yet. Share an insight, caveat, or question.
Rosado-Sanz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: